Trades in Immunovaccine shares to be undone after hoax spurs 30 pct jump

TORONTO, March 3 (Reuters) - Canada's stock market regulator said on Tuesday it will amend or cancel trades in the shares of tiny pharmaceutical company Immunovaccine Inc after they surged on Friday following a hoax.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.